Archives

by in
Entry Author Date Location
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten 10/08/09 Boston
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner 08/07/09 Boston
Biogen Idec, Trying to Go Beyond Rituxan, Assembles Cancer Drug Pipeline 07/16/09 Boston
GSK Cuts Deal with Concert to the Tune of a Potential $1B, Celldex Inks $94.5M CuraGen Acquisition, Aveo Touts Kidney Cancer Drug Data, & More Boston-Area Life Sciences News 06/03/09 Boston
ASCO Weekend Highlights: ImmunoGen, Antigenics, Aveo Show Off Cancer Drug Findings 06/01/09 Boston
Infinity Sees Comeback Potential for Cancer Drug that Failed 06/01/09 Boston
Biogen Idec Rebuts Icahn Attack, GlaxoSmithKline Quietly Spins Off Tempero Pharmaceuticals, Knome Launches Cheaper Sequencing Service, & More Boston-Area Life Sciences News 05/20/09 Boston
ASCO Sneak Peek: ImmunoGen, Biogen Idec, Infinity Show Glimpses of Cancer Drug Data 05/15/09 Boston
Group Names IBM, Zeemote, Infinity, Wolfe Executives as Leading Women Entrepreneurs 05/05/09 Boston
Innovating Through the Downturn: The View from the Nantucket Conference 05/05/09 Boston
Infinity Halts Trial of Lead Cancer Drug, Tysabri Sales Short of Projections, Myomo Slashes Staff, & More Boston-Area Life Sciences News 04/22/09 Boston
Infinity Pharma Lead Cancer Drug Trial Halted, Ends in Failure 04/15/09 Boston
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter 03/17/09 Boston
Biogen Idec Parkinson’s Drug Hits Goal in Pair of Mid-Stage Trials 01/13/09 Boston
Genzyme and Boston Scientific Get Good News From the FDA; Acusphere and Targanta Not So Much; TransMedics Pulls IPO Plug; & More Boston-Area Life Sciences News 12/17/08 Boston
Infinity Pharmaceuticals Gets Back Full Rights to Cancer Drugs From AstraZeneca 12/11/08 Boston
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News 11/26/08 Boston
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter 11/25/08 Boston
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News 11/24/08 Boston
Vertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News 10/22/08 Boston
Infinity Starts Trial of Hedgehog Pathway Blocker 10/16/08 Boston
Vertex Cystic Fibrosis Program on the Rise, Biogen and Partner Fall on Tysabri News, Alnylam Stakes RNAa IP Claim, & More Life Sciences News 08/06/08 Boston
Infinity Pharmaceuticals Starts First Clinical Trial of Oral Hsp-90 Blocker 07/30/08 Boston
Infinity Adds Two New Members To Board of Directors 07/22/08 Boston
MIT and Startup Sue Affymetrix, Enlight Garners Big Pharma Backers, Genocea Targets Cheaper Vaccines, & More Life Sciences News 07/16/08 Boston
Infinity Pharmaceuticals Pulls Plug on Treatment for Prostate Cancer 07/14/08 Boston
Xconomy Forum, December 5: The Future of Innovation in New England 11/08/07 Boston
Page 3 of 3 « previous page